Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma

Abstract Objective To determine the effect of clinical status (weight variation and performance status [PS]) at diagnosis and during induction treatment on resectability and overall survival (OS) rates in patients with borderline resectable (BRPC) or locally advanced pancreatic cancer (LAPC). Method...

Full description

Bibliographic Details
Main Authors: Pauline Duconseil, Jonathan Garnier, Victoria Weets, Jacques Ewald, Ugo Marchese, Marine Gilabert, Laurence Moureau-Zabotto, Flora Poizat, Marc Giovannini, Jean-Robert Delpero, Olivier Turrini
Format: Article
Language:English
Published: BMC 2019-06-01
Series:World Journal of Surgical Oncology
Online Access:http://link.springer.com/article/10.1186/s12957-019-1637-1
id doaj-a5b7c05fe76241b0b2032fe6ad441fc2
record_format Article
spelling doaj-a5b7c05fe76241b0b2032fe6ad441fc22020-11-25T03:34:21ZengBMCWorld Journal of Surgical Oncology1477-78192019-06-011711710.1186/s12957-019-1637-1Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinomaPauline Duconseil0Jonathan Garnier1Victoria Weets2Jacques Ewald3Ugo Marchese4Marine Gilabert5Laurence Moureau-Zabotto6Flora Poizat7Marc Giovannini8Jean-Robert Delpero9Olivier Turrini10Department of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Oncology, Institut Paoli-CalmettesDepartment of Radiotherapy, Institut Paoli-CalmettesDepartment of Pathology, Institut Paoli-CalmettesDepartment of Endoscopy, Institut Paoli-CalmettesDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMDepartment of Surgical Oncology, Institut Paoli Calmettes, Aix-Marseille University, CRCMAbstract Objective To determine the effect of clinical status (weight variation and performance status [PS]) at diagnosis and during induction treatment on resectability and overall survival (OS) rates in patients with borderline resectable (BRPC) or locally advanced pancreatic cancer (LAPC). Methods From 2005 to 2017, 454 consecutive patients were diagnosed with LAPC or BRPC. We evaluated the PS (0–1 or 2–3), body mass index at diagnosis, and weight loss (WL) > 5% at initial staging and after induction treatment and separated continuous weight loss (CWL) from weight stabilization. Results A total of 294 patients (64.8%) presented with WL, and 57 patients (12.6%) presented with a PS of 2–3. At restaging, 60 patients (13.2%) presented with CWL. Independent factors that poorly influenced the OS were a PS of 2–3 at diagnosis (P < .01), CWL at restaging (P < .01), and absence of resection (P < .01). Factors independently impeding resection were LAPC (P < .01), PS > 1 at diagnosis (P < .01), and CWL (P = .01). In total, 142 patients (31.3%) underwent pancreatectomy. Independent factors that poorly influenced the OS in the resected group were PS > 0 at diagnosis (P = .01) and obesity (P < .01). For the 312 unresected cancer patients (68.7%), CWL (P < .01) was identified as an independent factor that poorly influenced the OS. Conclusion Clinical parameters that are easy to measure and monitor are independent factors of poor prognosis. The variation of weight during the induction treatment, more than WL at diagnosis, significantly precluded resection and was an independent factor of shorter OS in unresected patients.http://link.springer.com/article/10.1186/s12957-019-1637-1
collection DOAJ
language English
format Article
sources DOAJ
author Pauline Duconseil
Jonathan Garnier
Victoria Weets
Jacques Ewald
Ugo Marchese
Marine Gilabert
Laurence Moureau-Zabotto
Flora Poizat
Marc Giovannini
Jean-Robert Delpero
Olivier Turrini
spellingShingle Pauline Duconseil
Jonathan Garnier
Victoria Weets
Jacques Ewald
Ugo Marchese
Marine Gilabert
Laurence Moureau-Zabotto
Flora Poizat
Marc Giovannini
Jean-Robert Delpero
Olivier Turrini
Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
World Journal of Surgical Oncology
author_facet Pauline Duconseil
Jonathan Garnier
Victoria Weets
Jacques Ewald
Ugo Marchese
Marine Gilabert
Laurence Moureau-Zabotto
Flora Poizat
Marc Giovannini
Jean-Robert Delpero
Olivier Turrini
author_sort Pauline Duconseil
title Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
title_short Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
title_full Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
title_fullStr Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
title_full_unstemmed Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
title_sort effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2019-06-01
description Abstract Objective To determine the effect of clinical status (weight variation and performance status [PS]) at diagnosis and during induction treatment on resectability and overall survival (OS) rates in patients with borderline resectable (BRPC) or locally advanced pancreatic cancer (LAPC). Methods From 2005 to 2017, 454 consecutive patients were diagnosed with LAPC or BRPC. We evaluated the PS (0–1 or 2–3), body mass index at diagnosis, and weight loss (WL) > 5% at initial staging and after induction treatment and separated continuous weight loss (CWL) from weight stabilization. Results A total of 294 patients (64.8%) presented with WL, and 57 patients (12.6%) presented with a PS of 2–3. At restaging, 60 patients (13.2%) presented with CWL. Independent factors that poorly influenced the OS were a PS of 2–3 at diagnosis (P < .01), CWL at restaging (P < .01), and absence of resection (P < .01). Factors independently impeding resection were LAPC (P < .01), PS > 1 at diagnosis (P < .01), and CWL (P = .01). In total, 142 patients (31.3%) underwent pancreatectomy. Independent factors that poorly influenced the OS in the resected group were PS > 0 at diagnosis (P = .01) and obesity (P < .01). For the 312 unresected cancer patients (68.7%), CWL (P < .01) was identified as an independent factor that poorly influenced the OS. Conclusion Clinical parameters that are easy to measure and monitor are independent factors of poor prognosis. The variation of weight during the induction treatment, more than WL at diagnosis, significantly precluded resection and was an independent factor of shorter OS in unresected patients.
url http://link.springer.com/article/10.1186/s12957-019-1637-1
work_keys_str_mv AT paulineduconseil effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT jonathangarnier effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT victoriaweets effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT jacquesewald effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT ugomarchese effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT marinegilabert effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT laurencemoureauzabotto effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT florapoizat effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT marcgiovannini effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT jeanrobertdelpero effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
AT olivierturrini effectofclinicalstatusonsurvivalinpatientswithborderlineorlocallyadvancedpancreaticadenocarcinoma
_version_ 1724559241386131456